Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
245
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
-282K
-
Total reported value, excl. options
-
$3.36B
-
Value change
-
-$28.6M
-
Put/Call ratio
-
1.94
-
Number of buys
-
117
-
Number of sells
-
-110
-
Price
-
$92.46
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2015
266 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q3 2015.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 152M outstanding shares and own 23.83% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.55M shares), BROWN CAPITAL MANAGEMENT LLC (2.44M shares), BlackRock Fund Advisors (1.74M shares), Jackson Square Partners, LLC (1.73M shares), JANUS CAPITAL MANAGEMENT LLC (1.48M shares), BAMCO INC /NY/ (1.4M shares), Mairs & Power INC (1.29M shares), Neuberger Berman Group LLC (1.29M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1.26M shares), and FIRST TRUST ADVISORS LP (1.26M shares).
This table shows the top 245 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.